Coming soon: $100 EpiPen alternative

Mark Baum believes the relentless EpiPen price hikes are "shameful" and his company is plotting a $100 alternative for the lifesaving allergy treatment. Baum, known for offering a $1 substitute for the $750 AIDS drug Daraprim, told CNNMoney on Tuesday that his company Imprimis Pharmaceuticals (IMMY) has been quietly working on a compounded version of EpiPen for months. The company hopes to have it ready by the end of the year.
Read more: http://money.cnn.com/2016/08/30/investing/epipen-alternative-100-dollars/index.html?source=Snapzu